NLS Intellectual Property

The United States Patent and Trademark Office has issued a patent titled ‘Neurotrophic factor MANF and uses thereof’ to Finnish Herantis Pharma. MANF, or mesencephalic astrocyte-derived neurotrophic factor, is used for the treatment of neurological diseases including Parkinson’s disease, epilepsy and ischemic brain injury. “MANF is the only known neurotrophic and neuroprotective factor similar to […]

On May 2nd 2017 SciBase received confirmation that its US patent, protecting the shape of the microneedles that enable detection of malignant melanoma in the skin using electrical impedance, has been approved. In total SciBase now has 3 patent families approved in the US and an additional family in process. “Our electrode design is one […]

The Swedish Patent and Market Court of Appeal has announced its judgment in a case concerning a subcontracting agreement, related to a public procurement of clinical physiology services. The Patent and Market Court of Appeal dismissed the Swedish Competition Authority’s request for fines and acquits Capio S:t Göran’s Hospital (CStG). The judgment sets aside a […]

Vironova has been granted a US patent with the title “A method for automatic correction of astigmatism”. Their method removes a manual step that requires considerable operator skill. It can be applied to any electron microscope, allowing for automated correction of the electron beam and ultimately enabling fully automated image acquisition. An important feature of […]

SCA won an important victory before the United States Supreme Court on March 21, 2017 in its seven-year patent infringement case against First Quality Products, Inc. In a 7-1 decision written by Justice Alito, the Supreme Court concluded that the six-year statutory period of limitations during which a patent infringement claim must be commenced cannot […]

Idogen announces that the European Patent Office will formally grant a patent application, covering the company’s tolerogenic vaccine technology. The EPO approval strengthens the company’s patent portfolio for the vaccine technology. A patent in the same patent family has already been granted in Japan and a Notice of Allowance has been received from the USA. […]